When JoAnna Coffey tore her left ACL ski racing at age 12, she met with more than four different surgeons in and around her hometown of Aspen. At the time, many doctors were very hesitant to operate on me, as I was young and still growing, Coffey says. Finally, someone recommended Dr
SAN DIEGO, May 11, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc.(Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today will give multiple oral and poster presentations at the American Society of Gene and Cell Therapy 2021 Virtual Annual Meetingbeing held May 11-14, 2021. The Company's oral presentation will highlight new data demonstrating the potential of its proprietary piggyBac DNA Delivery System for the treatment of genetic liver disorders in children and infants. Two additional presentations will highlight preclinical data supporting Poseida's first allogeneic CAR-T product candidate, P-BCMA-ALLO1 for R/R multiple myeloma, as well as preclinical data supporting the Company's anti-c-kit CAR-T program as a potentially safer preconditioning regimen for hematopoietic stem cell transplantation in patients with AML.
Many women experience debilitating menopause symptoms. Fledgling interventions aimed at delaying menopause or treating symptoms are attracting commercial interest, but robust evidence of potential benefit and harms for patients is lacking
during the forecast period. Growth in this market is majorly driven by the increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market
More than 34 million people in the United States have diabetes, and 9095% of these cases are type 2 diabetes. The cells of people with diabetes are less responsive to insulin, which is the hormone that allows tissues throughout the body to take up glucose from the bloodstream. One symptom that indicates that a person may be in the early stages of type 2 diabetes is reduced grip strength.
Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property
Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHCU), a special purpose acquisition company (SPAC) sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced they have entered into a definitive business combination agreement.
BioXcellerator Presented by BioXcellerator We recently shined a light on stem cell therapy (SCT) and its great potential with wellness, health, recovery and at-times life-changing treatments.Our focus centered on the esteemed BioXcellerator clinic in Medelln, Colombia, and how their treatments can extend longevity, boost immunity and enhance overall quality of life while reducing the impact of aging. To further this message, we will speak with real-life patients of BioXcellerator who have taken their treatments and experienced first-hand the efficacy of this promising future medicine. First up we have Dr
Fastingis the willful refraining from eating and drinking. In a physiological context, fastingmay be referred to the metabolic status of a person who has not eaten overnight, or to the metabolic state achieved after complete digestion and absorption of a meal. Several metabolic adjustments occur during fasting
In Aldous Huxley's 1932 novel Brave New World," people aren't born from a mother's womb. Instead, embryos are grown in artificial wombs until they are brought into the world, a process called ectogenesis. In the novel, technicians in charge of the hatcheries manipulate the nutrients they give the fetuses to make the newborns fit the desires of society
Recent Comments